Mohammad Y. Alshahrani

According to our database, Mohammad Y. Alshahrani authored at least 6 papers between 2021 and 2026.

Collaborative distances:

• Dijkstra number of five.
• Erdős number of five.

2026

Computational aspects and dynamical analysis of a novel HIV/AIDS transmission model with fractional temporal evolution.

Nauman Raza, Muhammad Asad Ullah, Mohammad Y. Alshahrani, Andrew Omame, Amna Hayat

Math. Comput. Simul., 2026

2025

The exploring AI-generated pyrazalone derivatives as antifungal agents: Bringing together molecular docking and quantum chemical approaches.

Muath Suliman, Aqsa Laraib, Shamsa Bibi, Shimmaa Mansour Moustafa Mohamed, Mohammad Y. Alshahrani, Shabbir Muhammad

Comput. Biol. Chem., 2025

In-silico discovery of efficient second-generation drug derivatives with enhanced antihistamine potency and selectivity.

Mohammad Y. Alshahrani, Ariha Zaid, Muath Suliman, Shamsa Bibi, Shabbir Muhammad, Shafiq Urréhman

Comput. Biol. Chem., 2025

2024

Computational prediction for designing novel ketonic derivatives as potential inhibitors for breast cancer: A trade-off between drug likeness and inhibition potency.

Shabbir Muhammad, Nimra Zahir, Shamsa Bibi, Mohammad Y. Alshahrani, Shafiq Urréhman, Aijaz Rasool Chaudhry, Fatima Sarwar, Muhammad Imran Tousif

Comput. Biol. Chem., 2024

Investigation of dual inhibition of antibacterial and antiarthritic drug candidates using combined approach including molecular dynamics, docking and quantum chemical methods.

Shabbir Muhammad, Amina Faiz, Shamsa Bibi, Shafiq Ur Rehman, Mohammad Y. Alshahrani

Comput. Biol. Chem., 2024

2021

High-throughput virtual screening and preclinical analysis identifies CB-1, a novel potent dual B-Raf/c-Raf inhibitor, effective against wild and mutant variants of B-Raf expression in colorectal carcinoma.

Mesfer Al Shahrani, Mohammad Abohassan, Mohammad Y. Alshahrani, Abdulrahim R. Hakami, Prasanna Rajagopalan

J. Comput. Aided Mol. Des., 2021